Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Immunic ( (IMUX) ) just unveiled an update.
On April 14, 2026, Immunic, Inc. held a Special Meeting of Stockholders at which investors approved a proposal authorizing the board to implement a reverse stock split of the company’s common stock at a ratio between 1-for-10 and 1-for-30. Of the 130,464,825 outstanding shares as of the record date, 54.1% were present or represented by proxy, and the proposal passed with 57,404,749 votes for, 12,594,555 against and 623,363 abstentions.
Following the approval, the board set the reverse stock split ratio at 1-for-10, with the split expected to become effective at 12:01 a.m. Eastern Time on April 27, 2026. The post-split shares will continue to trade on the Nasdaq Capital Market under the existing ticker IMUX, but with a new CUSIP identifier, signaling a significant adjustment to Immunic’s capital structure that may affect trading dynamics and per-share pricing for existing stockholders.
The most recent analyst rating on (IMUX) stock is a Buy with a $7.00 price target. To see the full list of analyst forecasts on Immunic stock, see the IMUX Stock Forecast page.
Spark’s Take on IMUX Stock
According to Spark, TipRanks’ AI Analyst, IMUX is a Neutral.
The score is held down primarily by weak financial performance (no revenue, large losses, and persistent cash burn with negative equity). Offsetting this, corporate events are constructive (Nasdaq compliance regained and substantial financing), while technicals are mixed and valuation metrics are unfavorable due to ongoing losses and no dividend.
To see Spark’s full report on IMUX stock, click here.
More about Immunic
Immunic, Inc. is a biopharmaceutical company whose common stock trades on the Nasdaq Capital Market under the symbol IMUX. The company’s shares are structured as common stock with a par value of $0.0001 per share, and its capital markets activity is overseen by a board of directors and stockholders who vote on key corporate actions.
Average Trading Volume: 3,554,513
Technical Sentiment Signal: Buy
Current Market Cap: $152.6M
Find detailed analytics on IMUX stock on TipRanks’ Stock Analysis page.